A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Leyland-Jones Brian; Bondarenko Igor; Nemsadze Gia; Smirnov Vitaliy; Litvin Iryna; Kokhreidze Irakli; Abshilava Lia; Janjalia Mikheil; Li Rubi; Lakshmaiah Kuntegowda C.; Samkharadze Beka; Tarasova Oksana; Mohapatra Ranjan Kumar; Sparyk Yaroslav; Polenkov Sergey; Vladimirov Vladimir; Xiu Liang; Zhu Eugene; Kimelblatt Bruce; Deprince Kris; Safonov Ilya; Bowers Peter; Vercammen Els

首页> 外文期刊>Journal of Clinical Oncology >A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

【24h】

A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

机译：随机开放标签，多中心，血液素Alfa对贫血患者的最佳护理标准，接受标准化疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2016年第11期|共13页
作者
Leyland-Jones Brian; Bondarenko Igor; Nemsadze Gia; Smirnov Vitaliy; Litvin Iryna; Kokhreidze Irakli; Abshilava Lia; Janjalia Mikheil; Li Rubi; Lakshmaiah Kuntegowda C.; Samkharadze Beka; Tarasova Oksana; Mohapatra Ranjan Kumar; Sparyk Yaroslav; Polenkov Sergey; Vladimirov Vladimir; Xiu Liang; Zhu Eugene; Kimelblatt Bruce; Deprince Kris; Safonov Ilya; Bowers Peter; Vercammen Els;
展开▼
作者单位

Avera Canc Inst Sioux Falls SD 57105 USA;

Dnepropetrovsk Med Acad Dnepropetrovsk Ukraine;

LTD K Madichi Mammol Ctr Inst Clin Oncol Tbilisi Rep of Georgia;

Donetsk Reg Anticancer Ctr Donetsk Ukraine;

Dnepropetrovsk Reg Oncol Dispensary Dnepropetrovsk Ukraine;

Martin D Abeloff Lab Canc Res Ctr Tbilisi Rep of Georgia;

Chemotherapy &

Immunotherapy Clin Medulla Tbilisi Rep of Georgia;

Tbilisi Canc Ctr Tbilisi Rep of Georgia;

St Lukes Med Ctr Quezon City Philippines;

Kidwai Mem Inst Oncol Bangalore Karnataka India;

Res Inst Clin Med Tbilisi Rep of Georgia;

Inst Med Radiol Kharkov Ukraine;

Apollo Specialty Hosp Madras Tamil Nadu India;

Lviv State Oncol Reg Treatment &

Diagnost Ctr Lvov Ukraine;

Chernigov Reg Oncol Ctr Chernigov Ukraine;

Pyatigorsk Oncol Dispensary Pyatigorsk Russia;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

Janssen Res &

Dev Raritan NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy [J] . Leyland-Jones Brian, Bondarenko Igor, Nemsadze Gia, Journal of Clinical Oncology . 2016,第11期

机译：依泊汀阿尔法与最佳治疗标准的随机，开放标签，多中心，III期研究，对接受标准化疗的贫血转移性乳腺癌患者
2. How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? [J] . Hasegawa Takahiro, Uno Hajime, Wei Lee-Jen Journal of Clinical Oncology . 2016,第31期

机译：如何总结依泊汀阿尔法与最佳护理标准对转移性乳腺癌接受标准化学疗法的贫血患者的安全性？
3. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study. [J] . Santini D, Vincenzi B, La Cesa A, Anticancer Research: International Journal of Cancer Research and Treatment . 2005,第1B期

机译：在接受化疗的贫血癌症患者中有效的新剂量密集型依泊汀α治疗方案：一项开放标签，非随机，先导研究。
4. Is High-Dose Chemotherapy Plus Stem-Cell Transplant the Standard Treatment for Patients Failing First-Line Chemotherapy for Metastatic Germ Cell Tumor? [C] . Christian Kollmannsberger, Lawrence Einhorn, Craig Nichols Genitourinary Cancers Symposium. . 2014

机译：高剂量化疗加干细胞移植对转移细胞肿瘤的一线化疗失败的患者的标准治疗吗？
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? [O] . Takahiro Hasegawa, Hajime Uno, Lee-Jen Wei -1

机译：如何总结依泊汀阿尔法与最佳护理标准对转移性乳腺癌接受标准化疗的贫血患者的安全性？
7. Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. [O] . P. Pronzato, Enrico Cortesi, C.C. Van Der Rijt, 2010

机译：Epoetin alfa可改善接受骨髓毒性化疗的乳腺癌患者的贫血和与贫血相关的患者报告的预后：一项欧洲，多中心，随机对照试验的结果。
8. Randomized, Double Blind, Placebo controlled Trial of Neuroprotective Effects of Epoetin Alfa in Patients Receiving Adjuvant Chemotherapy for Breast Cancer [R] . Abraham, J. , Haut, M. , Marano, G. , 2005

机译：Epoetin alfa对乳腺癌辅助化疗患者的神经保护作用的随机，双盲，安慰剂对照试验

A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅